title: Post-transplant lymphoproliferative disorder presenting as multiple myeloma.
authors.forename: Mary J
authors.initials: MJ
authors.lastname: Ninan
authors.forename: Yvonne H
authors.initials: YH
authors.lastname: Datta
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage; D003928:Diabetic Nephropathies / Q000601:surgery; D018450:Disease Progression; D020031:Epstein-Barr Virus Infections / Q000188:drug therapy / Q000209:etiology* / Q000821:virology; D017809:Fatal Outcome; D015774:Ganciclovir / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016030:Kidney Transplantation; D008159:Lumbar Vertebrae; D008232:Lymphoproliferative Disorders / Q000188:drug therapy / Q000209:etiology* / Q000821:virology; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy / Q000209:etiology* / Q000821:virology; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D016035:Pancreas Transplantation; D010954:Plasmacytoma / Q000188:drug therapy / Q000532:radiotherapy; D011183:Postoperative Complications / Q000209:etiology* / Q000821:virology; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects*; D012086:Reoperation; D000069283:Rituximab; D013125:Spinal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D016559:Tacrolimus / Q000008:administration & dosage / Q000009:adverse effects*; D013792:Thalidomide / Q000008:administration & dosage
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; D000069283:Rituximab; D013792:Thalidomide; D003520:Cyclophosphamide; D009173:Mycophenolic Acid; D015774:Ganciclovir; D011241:Prednisone; D016559:Tacrolimus